SNC
VPHM

Stifel Nicolaus & Co’s VIROPHARMA INC VPHM Stock Holding History

Stifel Nicolaus & Co’s Portfolio VPHM Stock Details VPHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$417K Sell
10,625
-5,113
-32% -$167K 0.01% 984
2013
Q2 		$451K Buy
+15,738
New +$415K 0.01% 893

Other funds holding VPHM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stifel Nicolaus & Co's VPHM Position: Q3 2013 in Review

Stifel Nicolaus & Co reduced its VIROPHARMA INC (VPHM) stake by 32% in Q3 2013, selling an estimated $167K and leaving 10,625 shares worth $417K. The position accounts for 0.01% of the portfolio, ranked #984.

Stifel Nicolaus & Co first reported a position in VPHM in Q2 2013 and has held it in 2 quarters since. The position peaked at $451K in Q2 2013. 191 funds tracked by Wall St. Rank hold VPHM as of Q3 2013.

  • Stifel Nicolaus & Co held 10,625 shares of VIROPHARMA INC worth $417K as of Q3 2013.
  • Stifel Nicolaus & Co sold 5,113 VIROPHARMA INC shares in Q3 2013, an estimated $167K.
  • VIROPHARMA INC made up 0.01% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #984 holding.
  • Stifel Nicolaus & Co first reported a position in VIROPHARMA INC in Q2 2013 and has held it in 2 quarters since.
  • Stifel Nicolaus & Co's VIROPHARMA INC position peaked at $451K in Q2 2013.
  • 191 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.